Mask wearing woman in a class full of students
Past Webinars
Insights for Managing Perinatal Medications for Opioid Use Disorder (OUD)
Friday, May 29, 2026

This module is designed to explore trends, emerging topics, medication options, general recommendations, and practical considerations for the treatment of OUD in pregnancy. Learners will explore how to manage pregnant and postpartum patient cases with medications for OUD.

Learning Objectives

Upon completion of this module, participants will be able to:

  • Evaluate the impact of OUD on maternal and fetal health outcomes
  • Explore evidence-based guidelines and recommendations for the screening, diagnosis, and management of OUD during pregnancy
  • Evaluated and assess the pharmacological differences in pregnancy and option for treatment of OUD
  • Define neonatal opioid withdrawal syndrome (NOWS), including its clinical presentation, risk factors, and diagnostic criteria, to facilitate early identification and intervention
Barbara V. Parilla, MD, FACOG, FASAM
Barbara V. Parilla, MD, FACOG, FASAM
Dr. Parilla is a Professor of Obstetrics and Gynecology at University of Kentucky College of Medicine and serves as the Gloria W. Singletary Endowed Chair of Women's Health. She is the Medical Director of the PATHways program, which provides comprehensive care and treatment for pregnant individuals with substance use disorders, and serves as Program Director for the Maternal-Fetal Medicine Fellowship.

Board certified in Obstetrics and Gynecology, Maternal-Fetal Medicine, and Addiction Medicine, Dr. Parilla is a recognized leader in the care of pregnant patients with substance use disorders. She is an active member of American Society of Addiction Medicine and received the March of Dimes Jonas Salk Health Leadership Physician Award for her work in this field. Dr. Parilla earned her MD with Distinction in Research from Renaissance School of Medicine at Stony Brook University and completed training at NYU Langone Hospital Long Island and Northwestern University.

KDPH Immunization Branch: Perinatal Hepatitis B Prevention
Friday, April 24, 2026

 

Hepatitis B virus (HBV) infection during the perinatal period remains a preventable cause of chronic liver disease in infants. Without appropriate post-exposure prophylaxis, up to 90% of infants infected at birth will develop chronic HBV infection, placing them at increased risk for cirrhosis and hepatocellular carcinoma later in life. This presentation reviews the epidemiology of perinatal HBV transmission, recommended screening and testing during pregnancy, and the critical role of timely newborn vaccination and hepatitis B immune globulin (HBIG) administration. Emphasis will be placed on the importance of coordinated maternal screening, public health reporting, and immediate infant immunization to prevent vertical transmission. Strategies for addressing vaccine safety concerns and communicating effectively with vaccine-hesitant families will be discussed. Opportunities to strengthen collaboration between healthcare providers and public health programs to improve prevention of perinatal hepatitis B transmission will also be highlighted.

Roberta Butler, RN, MSN Perinatal Hepatitis B Coordinator
Roberta Butler, RN, MSN Perinatal Hepatitis B Coordinator

Roberta Butler, RN, MSN, is the Perinatal Hepatitis B Coordinator for the Kentucky Department for Public Health’s Immunization Hepatitis B Program. She earned her Master of Science in Nursing Education in 2003 and has dedicated over 30 years to caring for mothers and babies as a Labor and Delivery nurse.

Passionate about maternal and neonatal health, Roberta is committed to protecting families from vaccine-preventable diseases across Kentucky. She lives in Morehead, KY, with her husband of 43 years and is grateful for the opportunity to make a meaningful impact on public health.

From Physiology to Practice: Advancing Cardio-Obstetric Care and Collaboration in Kentucky
Friday, February 27, 2026

This webinar event will review the key physiologic changes that occur during pregnancy, highlight common cardiac conditions requiring specialized cardio-obstetrics management, and outline important anesthesia considerations for obstetric patients. In addition, we will share the KyMMM OB Task Force subcommittee’s efforts to develop a Kentucky‑wide cardio‑obstetric network aimed at improving access to expert cardiology support and providing ongoing education for healthcare providers across the state.

Kentucky Morbidity and Mortality Task Force Cardiac Conditions Committee
Kentucky Morbidity and Mortality Task Force Cardiac Conditions Committee

Ashley Boerrigter, MD Maternal Fetal Medicine

James Damron, MD Obstetric Anesthesia

Andrea Robinson

Transforming Care for Hypertensive Disorders in Pregnancy
Friday, January 30, 2026

Following completion of this course, learners should be able to: 

  1. Understand the Blue Band Project
  2. Implementation of the Blue Band Project
  3. Discuss the lived experience of a hypertensive disorder in pregnancy

For more information about KyMMM and the Blue Band Project: Home - Kentucky Maternal Morbidity & Mortality Task Force

Kentucky Maternal Morbidity and Mortality Task Force Hypertension Committee
Kentucky Morbidity and Mortality (KyMMM) Task Force Hypertension Committee

Michelle Williams, MA - KyMMM Hypertension Committee Chair

John O'Brien, MD - KyMMM Task Force Chair, University of Kentucky

Amy Wheeler, MSN, RNC-OB, C-EFM - Baptist Health System

Upcoming webinars